News & Events

6 ways computational chemistry can refine your drug discovery project

November 18, 2021

Using theory and informatic tools to help solve complex chemical problems, computational chemistry has revolutionized the way we practice science and develop drugs.

NuChem Sciences awards scholarships to three promising students in Canadian universities

September 23, 2021

NuChem Sciences is pleased to announce a new fellowship to support and mentor three outstanding doctoral graduate students in the fields of organic synthesis or medicinal chemistry.

NuChem Sciences joins forces with OmegaChem to become Canada’s CRO focused on chemistry

September 3, 2021

We are pleased to announce that NuChem Sciences is joining forces with OmegaChem to become Canada’s CRO focused on chemistry.

Minister of labour J. Boulet visits Nuchem Sciences

August 8, 2021

We had the pleasure of hosting a visit of Mr. Jean Boulet, the Minister of Labour, Employment and Social Solidarity and Minister responsible for the Mauricie region, in our state-of-the-art laboratories to discuss with members of our teams.

NuChem Sciences announces new Discovery Partner Program™

April 15, 2021

This new service offers our team’s superior talent and our cutting-edge scientific technology, paired with responsive communication, efficiency and clarity along the drug discovery journey.

NuChem Sciences launches new brand and announces new name

April 15, 2021

After experiencing exponential growth in recent years, NuChem Therapeutics is proud to launch its new brand identity. As part of this exciting step forward, we will adopt a new corporate name: NuChem Sciences.

Universite de Montreal Journee Carriere

January 15, 2020

Our team was happy to meet and greet students at the Universite de Montreal MIL Campus as part of the Journee Carriere event.

NuChem Therapeutics Completed the Acquisition of Amplia Pharmatek

October 19, 2019

Amplia Pharmatek is an innovative service provider who specializes in Discovery Biology, in vivo Pharmacology, Pharmacokinetics and Toxicology.

Completion of a Successful Management Buyout Transaction At NuChem Therapeutics

February 22, 2019

On December 13th 2018, senior management of the company, comprised of Marc LeBel, Daniel Guay, Marc Janes and John Mancuso, acquired 95% of the voting shares from Amorchem LP, the venture capital fund which founded NuChem in 2011.

Transform Ideas Through Science

A drug discovery and chemical development contract research organization.

NuChem Sciences Inc.

2350 Rue Cohen Suite 201
Saint-Laurent, Quebec
Canada H4R 2N6
514 416 5659

©2021 NuChem Sciences Inc. All Rights Reserved.